Stockreport

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis

Precision BioSciences, Inc.  (DTIL) 
Last precision biosciences, inc. earnings: 11/12 07:15 am Check Earnings Report
PDF – Milestone payments include $5.25 million cash and $2.25 million purchase of Precision stock–– Cash received supports Precision’s expected cash runway through 2028 and [Read more]